Reactions of 1 and 2 equiv of HOSi(O t Bu) 3 with Cr(O t Bu) 4 afforded the first Cr(IV) alkoxysiloxy complexes ( t BuO) 3 CrOSi(O t Bu) 3 ( 1 ) and ( t BuO) 2 Cr[OSi(O t Bu) 3 ] 2 ( 2 ), respectively. Both 1 and 2 contain pseudotetrahedral d 2 chromium centers and crystallize in the monoclinic space group P 2 1 / n with four molecules in the unit cell. The high-yielding, convenient synthesis of 1 makes this complex a useful single-source molecular precursor, via the thermolytic molecular precursor method, to Cr/Si/O materials. The thermal transformations of 1 and 2 to chromia−silica materials occurred at low temperatures (≤180 °C), to give isobutene as the major carbon-containing product. The material generated from the solid-state conversion of 1 ( CrOSi ss ) contained both micro- and mesoporosity with an unexpectedly high surface area of 315 m 2 /g that was slightly reduced to 275 m 2 /g after calcination at 500 °C in O 2 . The xerogel obtained by the thermolysis of an n -octane solution of 1 ( CrOSi xg ) had a surface area of 315 m 2 /g that was reduced to 205 m 2 /g upon calcination at 500 °C. The nitrogen adsorption−desorption isotherm for the xerogel had characteristics indicating both microporosity and textural mesoporosity. Powder X-ray diffraction (PXRD) analysis was used to demonstrate that Cr 2 O 3 was the only species that crystallized in CrOSi ss and CrOSi xg after calcination at temperatures up to 1200 °C in O 2 . Elemental analyses of these materials revealed that the Cr:Si ratio was very close to 1:1, indicating that the original stoichiometry of the precursor is retained upon thermal conversion to Cr/Si/O materials. Both materials contained very low amounts of carbon after calcination in O 2 at 500 °C. In the oxidative dehydrogenation of propane, CrOSi xg (calcined at 500 °C) displayed intrinsic activities for propene formation that were up to 3 times higher than those for CrOSi ss (calcined at 500 °C). In addition, the selectivity for propene formation was higher for the more active CrOSi xg catalyst.
No takes yet. Share an insight, caveat, or question.
Fujdala et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: